2
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
4
Unknown
3
Withdrawn
1
Terminated
1
Recruiting
1
Not yet recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
438
Neoplasms
322
Carcinoma, Non-Small-Cell Lung
250
Prostatic Neoplasms
240
Lung Neoplasms
176
Colorectal Neoplasms
158
Pancreatic Neoplasms
148
Neoplasm Metastasis
142
Leukemia, Myeloid, Acute
140
Multiple Myeloma
131
Lymphoma
128
Carcinoma, Hepatocellular
127
Ovarian Neoplasms
109
Melanoma
109
Head and Neck Neoplasms
101
Brain Neoplasms
101
Recurrence
100
Leukemia
97
Leukemia, Lymphocytic, Chronic, B-Cell
96
Precursor Cell Lymphoblastic Leukemia-Lymphoma
90
Glioblastoma
85
Lymphoma, Non-Hodgkin
83
Colonic Neoplasms
79
Squamous Cell Carcinoma of Head and Neck
76
Lymphoma, Follicular
76
Carcinoma, Renal Cell
75
Lymphoma, Large B-Cell, Diffuse
71
Hematologic Neoplasms
69
Sarcoma
60
Stomach Neoplasms
58
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Withdrawn
×
Airway Obstruction
×
Clear all
NCT01903850
2016-02-02
TAO
CSA Medical, Inc.
Phase 4
Withdrawn